Abstract:Background Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is a multifunctional Ig-like cell adhesion molecule that has a wide range of biological functions. According to previous reports, serum CEACAM1 is dysregulated in different malignant tumours and associated with tumour progression. However, the serum CEACAM1 expression in non-small-cell lung carcinomas (NSCLC) is unclear. The different expression ratio of CEACAM1-S and CEACAM1-L isoform has seldom been investigated in NSCLC. This research is intended to study the serum CEACAM1 and the ratio of CEACAM1-S/L isoforms in NSCLC. Methods The expression of the serum CEACAM1 was determined by enzyme-linked immunosorbent assay. The protein expression and the location of CEACAM1 in tumours were observed by immunohistochemical staining. The CEACAM1 mRNA levels in tumour and normal adjacent tissues were measured using quantitative real-time PCR, and the expression patterns and the rate of CEACAM1-S and CEACAM1-L were analysed by reverse transcription-PCR. Results Serum CEACAM1 levels were significantly higher in NSCLC patients compared with that from normal healthy controls ( P <0.0001). 17 patients (81%) among 21 showed high expression of CEACAM1 by immunohistochemical staining. Although no significant differences were found between tumour and normal tissues on mRNA expression levels of CEACAM1 ( P >0.05), the CEACAM1-S and the CEACAM1-S/L (S: L) ratios were significantly higher in tumour than normal tissues ( P <0.05). Conclusions Our data indicated that the serum levels of CEACAM1 could discriminate lung cancer patients from health donors and that CEACAM1 might be a useful marker in early diagnosis of NSCLC. Moreover, our results showed that the expression patterns of CEACAM1 isoforms could be changed during oncogenesis, even when total CEACAM1 in tumour tissues did not show significant changes. Our study suggested that the expression ratios of CEACAM1-S/CEACAM1-L might be a better diagnostic indicator in NSCLC than the quantitative changes of CEACAM1.

Characteristics of Carcinoembryonic antigen related cell adhesion molecules and their relationship to cancer

The CEA-/lo colorectal cancer cell population harbors cancer stem cells and metastatic cells.

The emerging roles of CEACAM6 in human cancer (Review)

CEACAM6 expression and function in tumor biology: a comprehensive review

Structure and Function of Human Carcinoembryonic Antigen-related Cellular Adhesion Molecule 1

Immunomodulatory roles of the carcinoembryonic antigen family of glycoproteins

Up-regulation of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Gastrointestinal Cancer and Its Clinical Relevance.

Carcinoembryonic antigen‐related cell adhesion molecule 1 in cancer: Blessing or curse?

Roles of CEACAM1 in cell communication and signaling of lung cancer and other diseases

Carcinoembryonic Antigen-Related Cell Adhesion Molecules (CEACAM) 1, 5 and 6 as Biomarkers in Pancreatic Cancer

Inhibition of Cell Invasion and Migration by CEACAM1-4S in Breast Cancer.

Clinicopathological Significance of CEACAM1 Gene Expression in Breast Cancer.

Clinical and experimental studies regarding the expression and diagnostic value of carcinoembryonic antigen-related cell adhesion molecule 1 in non-small-cell lung cancer

CEACAM1 Cytoplastic Expression is Closely Related to Tumor Angiogenesis and Poorer Relapse-Free Survival after Curative Resection of Hepatocellular Carcinoma.

Expression of carcinoembryonic antigen-related cell adhesion molecule 6 in pancreatic carcinoma tissues and its relationship with clinicopathological characteristics

Ceacam1 Dampens Antitumor Immunity by Down-Regulating Nkg2d Ligand Expression on Tumor Cells

Cell Motility and Spreading Promoted by CEACAM6 Through Cyclin D1/CDK4 in Human Pancreatic Carcinoma.

Carcinoembryonic Antigen Related Cell Adhesion Molecule 6 Promotes the Proliferation and Migration of Renal Cancer Cells Through the ERK/AKT Signaling Pathway

CEACAM1 Distribution and It’s Effects on Angiogenesis and Lymphangiogenesis in Oral Carcinoma

Characterizing the Tumor Suppressor Role of CEACAM1 in Multiple Myeloma.

Abnormal Expression of Circulating and Tumor-Infiltrating Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Patients with Glioma.